Cardiomyopathies

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Cardiovascular Diseases, Heart Diseases

Narrower: Cardiomyopathy, Dilated 1, Cardiomyopathy, Hypertrophic 2, Myocardial Reperfusion Injury 1, Myocarditis 1

Treatments and conditions

Cardiomyopathies
Treatment and conditionWhere it standsTrials
Colchicine for myocarditisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combined antioxidant therapy for myocardial reperfusion injuryTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for cardiomyopathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for cardiomyopathy, hypertrophicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
High Dose LX2006 + Low dose LX2006 + Mid Dose LX2006 for cardiomyopathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
hiPSC-CM therapy for cardiomyopathy, dilatedPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
NTLA-2001 for cardiomyopathiesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
RP-A501 for cardiomyopathy, hypertrophicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.